logo

For the Inventor, By the Inventor

Cambridge, MA, United States of America

Tcr2 Therapeutics Inc.

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 10.0


Forward Citations = 31

Loading Chart...
Loading Chart...

9 inventors (with patents filed for the assignee):

goldMedal Robert Hofmeister (9 out of 15 patents)

silverMedal Patrick A Baeuerle (9 out of 35 patents)

bronzeMedal Gregory Sieczkiewicz (8 out of 11 patents)

4.  Robert B Dubridge (1 out of 49 patents)

5.  Holger Wesche (1 out of 27 patents)

6.  Richard J Austin (1 out of 25 patents)

7.  Bryan D Lemon (1 out of 25 patents)

8.  Luca Melchiori (1 out of 1 patent)

9.  Joanna Brewer (1 out of 1 patent)

10.  Patrick Baeuerle (1 patent)


10 patents:

1. 12589151 - T Cell Modification (2026-03-31),
2. 11965012 - Compositions and methods for TCR reprogramming using fusion proteins (2024-04-23),
3. 11851491 - Compositions and methods for TCR reprogramming using fusion proteins (2023-12-26),
4. 11377638 - Compositions and methods for TCR reprogramming using fusion proteins (2022-07-05),
5. 11242376 - Compositions and methods for TCR reprogramming using fusion proteins (2022-02-08),
6. 11085021 - Compositions and methods for TCR reprogramming using fusion proteins (2021-08-10),
7. 11028142 - Compositions and methods for TCR reprogramming using fusion proteins (2021-06-08),
8. 10358474 - Compositions and methods for TCR reprogramming using fusion proteins (2019-07-23),
9. 10358473 - Compositions and methods for TCR reprogramming using fusion proteins (2019-07-23),
10. 10208285 - Compositions and methods for TCR reprogramming using fusion proteins (2019-02-19),
Company Overview
Tcr2 Therapeutics Inc. is a biotechnology company based in Cambridge, MA, focused on developing innovative T cell therapies for cancer treatment. The company specializes in harnessing the power of T cell receptor (TCR) technology to create targeted therapies that aim to improve patient outcomes in oncology. By leveraging advanced scientific research and proprietary platforms, Tcr2 Therapeutics is dedicated to addressing unmet medical needs in the field of cancer immunotherapy, contributing to the evolution of personalized medicine.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#231 in Cambridge, MA

#1,773 in Massachusetts

#29,882 in US

#56,092 in the World

Cambridge, MA (US)
Cambridge, MA, United States of America

Tcr2 Therapeutics Inc.

Forward Citations = 31

9 inventors:

goldMedal Robert Hofmeister (9 out of 15 patents)

silverMedal Patrick A Baeuerle (9 out of 35 patents)

bronzeMedal Gregory Sieczkiewicz (8 out of 11 patents)

4.  Robert B Dubridge (1 out of 49 patents)

5.  Holger Wesche (1 out of 27 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Tcr2 Therapeutics Inc.. Retrieved from https://idiyas.com/company/tcr2-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…